InpharmD vs IV Medications Elsevier
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
InpharmD
Access on-demand digital drug information tailored for healthcare providers. This app promotes evidence-based medicine by saving time and resources.
- On-demand digital drug information
- Tailored information for providers
- Promotes evidence-based medicine
- Saves time and resources
Read full descriptionHide full description
We save time and resources for healthcare providers by providing tailored, on demand, digital drug information, in order to promote evidence-based medicine.
IV Medications Elsevier
This comprehensive IV drug handbook provides nurses and health professionals with up-to-date information on over 400 intravenous drugs. It features quick-access monographs, highlighted warnings, and life-stage dosage variances to ensure safe and accurate medication administration.
- Over 400 IV drug monographs
- New FDA-approved drug updates
- Highlighted Black Box Warnings
- Life stage dosage variances
- Alphabetical drug format
- Annual publication
Read full descriptionHide full description
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. For nearly 50 years - #1 IV drug handbook to safely administer more than 400 intravenous drugs! Drug monographs for 10-20 newly approved drugs by the FDA include the most current information Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. New to this edition - New drug monographs for approximately 10-20 newly approved drugs by the FDA provides readers with the most current drug information - Each monograph updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors Key Features - Annual publication prevents users from referencing outdated information - 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration - Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference - Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page - Highlighted Black Box Warnings and relevant content make locating critical information fast and easy - Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings - Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds - Dilution and dosage charts within monographs provide quick access to essential clinical information - Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Content licensed from printed edition ISBN-10: 0443269599 Content licensed from printed edition ISBN-13: 9780443269592 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s):Shelly Rainforth Collins, PharmD Publisher:Elsevier Health Sciences
Screenshots
Verdict
The clearest difference is in-app purchases: InpharmD at none against IV Medications Elsevier's 8. InpharmD also leads on review sentiment (60% vs 33%) and update cadence (every 5 weeks vs every 5 months). IV Medications Elsevier's advantage is device support (4 vs 2) and iOS requirement (13.0 vs 18.0). On price, ratings volume, ads and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. IV Medications Elsevier sells 8 in-app purchases, starting at $25.99 per 3 months. InpharmD asks for nothing beyond the download.
InpharmD holds the better App Store score, 4.9 against 4.6. Both are backed by a comparable volume of ratings — 159 and 72 respectively. Written reviews point the same way: 60% of InpharmD's written reviews are positive against 33% of IV Medications Elsevier's.
InpharmD ships an update every 5 weeks, IV Medications Elsevier every 5 months. The most recent releases landed on October 23, 2026 and October 24, 2026 respectively.
| Parameter | InpharmD | IV Medications Elsevier |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (159 ratings) — better | 4.6 (72 ratings) |
| Positive reviews | 60.0% of reviews — better | 33.3% of reviews |
| Number of ratings | 159 — better | 72 |
| Update frequency | Every 5 weeks — better | Every 5 months |
| Ads | Yes | Yes |
| In-app purchases | No — better | Yes |
| Monetization | Free with in-app purchases | Free with in-app purchases |
| Devices | iPhone, iPad | iPhone, iPad, iPod, Mac — better |
| Requires iOS | 18.0 | 13.0 — better |
| Further details — not scored | ||
| Size | 47 MB | 149 MB |
| Age rating | 17+ | 17+ |
| Developer | InpharmD, LLC | Skyscape Medpresso Inc |
Customer experience
InpharmD
IV Medications Elsevier
In-app purchases
InpharmD
No in-app purchases
IV Medications Elsevier
- Elsevier’s IV Med HBK 3/M Sub$25.993 Months
- Elsevier’s IV Med HBK 6M Sub$32.996 Months
- 25% Off-Elsevier IVMed 1Y Sub$37.491 Year
Show 4 moreShow fewer
- Elsevier IV Med HBK 1Y Sub off$39.991 Year
- 20% Off-Elsevier IVMed 1Y Sub$39.991 Year
- 15% Off-Elsevier IVMed 1Y Sub$42.491 Year
- Elsevier’s IV Med HBK 1Y Sub1 Month trial$49.991 Year
- Intravenous Medications 2022$49.99
Questions
Is InpharmD free?
Is IV Medications Elsevier free?
Which has better reviews, InpharmD or IV Medications Elsevier?
Do InpharmD or IV Medications Elsevier have ads?
Which is updated more often, InpharmD or IV Medications Elsevier?
Other comparisons















